ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

KPTI Karyopharm Therapeutics Inc

1,11
0,02 (1,83%)
04 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Karyopharm Therapeutics Inc KPTI NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,02 1,83% 1,11 01:00:14
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
1,11 1,08 1,185 1,13 1,09
mais cotações »

Notícias Recentes

Data Hora Fonte Título
02/05/202417:30PRNUSKaryopharm to Report First Quarter 2024 Financial Results on..
01/05/202417:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
24/04/202417:01PRNUSKaryopharm Announces Presentations in Endometrial Cancer and..
01/04/202417:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
06/03/202418:05PRNUSKaryopharm to Participate at Barclays 26th Annual Global..
01/03/202418:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
29/02/202409:30PRNUSKaryopharm Reports Fourth Quarter and Full Year 2023..
22/02/202409:00PRNUSKaryopharm to Report Fourth Quarter and Full Year 2023..
01/02/202418:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
08/01/202410:30PRNUSKaryopharm Announces Preliminary Unaudited 2023 Revenue and..
03/01/202409:00PRNUSKaryopharm to Present at 42nd Annual J.P. Morgan Healthcare..
02/01/202418:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
10/12/202322:15PRNUSKaryopharm Shares Data at ASH 2023 Showing Strong SVR and..
01/12/202318:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
08/11/202318:05PRNUSKaryopharm to Participate at Upcoming Investor Conferences
06/11/202309:00PRNUSKaryopharm Announces New Preliminary Data in Overall..
02/11/202310:20PRNUSKaryopharm Announces Presentations at the 65th American..
02/11/202308:30PRNUSKaryopharm Reports Third Quarter 2023 Financial Results and..
30/10/202309:00PRNUSKaryopharm Announces Clinical Trial Collaboration with..
26/10/202308:00PRNUSKaryopharm to Report Third Quarter 2023 Financial Results on..
02/10/202317:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
26/09/202308:00PRNUSKaryopharm to Present Selinexor Data at the 2023..
05/09/202317:05PRNUSKaryopharm to Participate at Upcoming Investor Conferences
01/09/202317:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
01/09/202309:00PRNUSKaryopharm Appoints Zhen Su, MD, MBA to its Board of..
02/08/202308:30PRNUSKaryopharm Reports Second Quarter 2023 Financial Results and..
01/08/202317:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
26/07/202308:00PRNUSKaryopharm to Report Second Quarter 2023 Financial Results..
25/07/202316:00PRNUSKaryopharm Announces Presentation of Updated Exploratory..
19/07/202309:00PRNUSKaryopharm Announces Updated Exploratory Subgroup Analysis..
18/07/202311:15APSHealthcare Stock Bid Up Following FDA Fast Track
17/07/202317:48DJNKaryopharm Gets FDA Fast Track Designation for Myelofibrosis..
17/07/202317:05PRNUSKaryopharm Receives FDA Fast Track Designation for Selinexor..
05/07/202317:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
28/06/202309:00PRNUSKaryopharm Initiates Pivotal Phase 3 Study of XPO1 Inhibitor..
01/06/202317:05PRNUSKaryopharm Therapeutics Reports Inducement Grants Under..
01/06/202308:00PRNUSKaryopharm to Participate at the Jefferies Healthcare..
23/05/202317:05PRNUSKaryopharm to Present New Selinexor Data at the 2023..

Seu Histórico Recente

Delayed Upgrade Clock